AKRO vs. AVGO
Compare and contrast key facts about Akero Therapeutics, Inc. (AKRO) and Broadcom Inc. (AVGO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: AKRO or AVGO.
Correlation
The correlation between AKRO and AVGO is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
AKRO vs. AVGO - Performance Comparison
Key characteristics
AKRO:
1.48
AVGO:
1.55
AKRO:
3.88
AVGO:
2.26
AKRO:
1.44
AVGO:
1.31
AKRO:
2.46
AVGO:
3.48
AKRO:
8.12
AVGO:
9.60
AKRO:
20.79%
AVGO:
9.15%
AKRO:
114.20%
AVGO:
56.65%
AKRO:
-79.99%
AVGO:
-48.30%
AKRO:
-0.83%
AVGO:
-10.79%
Fundamentals
AKRO:
$4.30B
AVGO:
$1.04T
AKRO:
-$3.96
AVGO:
$1.28
AKRO:
$0.00
AVGO:
$39.61B
AKRO:
-$2.00K
AVGO:
$24.36B
AKRO:
-$178.57M
AVGO:
$19.21B
Returns By Period
In the year-to-date period, AKRO achieves a 102.77% return, which is significantly higher than AVGO's -4.06% return.
AKRO
102.77%
99.75%
128.57%
178.71%
16.01%
N/A
AVGO
-4.06%
-4.35%
55.47%
81.34%
51.88%
39.41%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
AKRO vs. AVGO — Risk-Adjusted Performance Rank
AKRO
AVGO
AKRO vs. AVGO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Akero Therapeutics, Inc. (AKRO) and Broadcom Inc. (AVGO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
AKRO vs. AVGO - Dividend Comparison
AKRO has not paid dividends to shareholders, while AVGO's dividend yield for the trailing twelve months is around 0.98%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AKRO Akero Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
AVGO Broadcom Inc. | 0.98% | 0.94% | 1.71% | 3.02% | 2.24% | 3.05% | 3.54% | 4.48% | 1.87% | 1.43% | 1.13% | 1.22% |
Drawdowns
AKRO vs. AVGO - Drawdown Comparison
The maximum AKRO drawdown since its inception was -79.99%, which is greater than AVGO's maximum drawdown of -48.30%. Use the drawdown chart below to compare losses from any high point for AKRO and AVGO. For additional features, visit the drawdowns tool.
Volatility
AKRO vs. AVGO - Volatility Comparison
Akero Therapeutics, Inc. (AKRO) has a higher volatility of 70.35% compared to Broadcom Inc. (AVGO) at 21.56%. This indicates that AKRO's price experiences larger fluctuations and is considered to be riskier than AVGO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
AKRO vs. AVGO - Financials Comparison
This section allows you to compare key financial metrics between Akero Therapeutics, Inc. and Broadcom Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities